A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis

ConclusionThe network analysis supports the use of DOACs in cirrhotic patients, with significant rates of complete recanalization compared to other treatments without increasing bleeding risk. DOACs can potentially be considered for nontumorous PVT in cirrhosis.
Source: Hepatology International - Category: Infectious Diseases Source Type: research